Frequent Q&A

Q: What is BioNAV, and why should we consider a partnership?
A: BioNAV is a patent-pending technology platform that enables the identification and classification of airborne particles using advanced computer vision and AI/ML. The resulting data can be securely transmitted through our PatientShare network, enabling individuals to share environmental exposure information with healthcare providers. Partnering with BioNAV allows you to embed your technology—whether hardware, software, or data analytics—into a scalable ecosystem positioned at the intersection of air quality, healthcare, and personal diagnostics. Early collaborators help shape our integration protocols and expand the ecosystem’s value proposition.

 

Q: How much does it cost to become a BioNAV license reseller?

A: Costs vary per reseller's industry focus. Please contact us to schedule a discovery meeting with a BioNAV representative. We'll be happy to answer questions, calculate upfront costs, and discuss qualifications.
 

Q: How can our technology integrate with BioNAV?
A: BioNAV supports modular integration at multiple levels of the data pipeline—from sensor capture to AI-based classification, through to patient-facing applications and secure data-sharing APIs. Your technology may contribute to:

• Particle image capture (e.g., through optical, radar, or spectrographic devices)

• AI/ML object recognition engines for particle classification

• Data storage and retrieval infrastructures

• Embedded or edge computing frameworks for onsite processing

All integrations are conducted within a secure, controlled environment, following mutually defined architecture standards and subject to Proof-of-Concept (PoC) review.
 

Q: What kind of flexibility does BioNAV offer for tech partners?
A: Through our ExtremeFlex™ architecture, BioNAV is designed for adaptability. Partners may configure how air particle data is collected, analyzed, stored, and transmitted. Integration methods can be tailored to your organization’s existing platforms—whether you're contributing device-level firmware, cloud-based analytics, or interoperable EHR modules. We accommodate a wide range of use cases, from low-latency edge deployments to full cloud-based infrastructures.
 

Q: What are the commercial and revenue opportunities for partners?
A: BioNAV’s licensing model is designed to grow with adoption. Our usage-based and tiered revenue frameworks allow partners to:

• Monetize their AI/ML capabilities within the particle ID process

• Co-brand or white-label features for industry-specific applications

• Participate in recurring revenue streams tied to annual licensing, mobile app analytics, and custom reporting for end-user organizations

Additionally, partners can gain access to new B2B channels in healthcare, insurance, building systems, automotive, aerospace, and smart consumer technologies.
 

Q: How does BioNAV maintain data security and compliance across integrated solutions?
A: Data security is foundational to BioNAV’s platform. Our infrastructure includes:

• End-to-end encryption (at rest and in transit)

• Role-based access controls (RBAC)

• Multi-factor authentication (MFA)

• Federated identity management (Okta, Active Directory, LDAP support)

• Secure provisioning/deprovisioning

• Audit trails and tokenized metadata for all processed air particle data

We are actively developing protocols to align with HIPAA, ISO/IEC 27001, and emerging digital identity standards for decentralized healthcare ecosystems.
 

Q: What integration and development support is available to partners?
A: BioNAV provides:

• A dedicated sandbox environment for testing integrations

• RESTful APIs and webhooks for secure data exchange

• Technical documentation and data schema support

• Access to a pilot-level Proof-of-Concept (PoC) program, designed to assess system compatibility and generate actionable feedback before full deployment

Our technical and advisory teams work closely with your developers to ensure alignment with existing infrastructure and performance expectations.

Q: Why partner with BioNAV now?
A: BioNAV is pioneering the delivery of AI data that links air-filtration directly to respiratory health. As governments, health systems, and consumers place increasing emphasis on environmental health, early partners will be positioned to influence emerging standards in environmental diagnostics, data interoperability, and predictive respiratory care. Whether your organization focuses on sensors, AI, infrastructure, or digital health tools, BioNAV represents an opportunity to co-develop impactful, scalable solutions in an underdeveloped and high-growth market.

Q: What industries can benefit from BioNAV's technology integration?
A: Our platform is industry-agnostic but is currently most aligned with:

• Healthcare (EHR systems, digital health platforms, remote diagnostics)

• Building technology (HVAC manufacturers, indoor air quality monitoring)

• Automotive and aerospace (cabin filtration, passenger safety systems)

• Insurance (environmental exposure modeling, preventative care analytics)

• Scientific instrumentation and R&D
   

Q: What makes BioNAV's offering unique compared to traditional air monitoring systems?
A: Traditional systems often focus on aggregate air quality metrics (e.g., AQI). BioNAV analyzes physical air particle debris at the point of capture—offering object-level identification (e.g., pollen, mold, industrial residue). The data is contextualized through AI and made shareable through a patient-managed app. This granular, user-specific approach enables proactive health decisions and personalized environmental risk tracking.